effector.com (EFTR): Prakiraan wutah bathi resik saben saham kanggo taun ngarep

Tandha merek eEFFECTOR (EFTR)

eFFECTOR Therapeutics (EFTR) is developing a cancer therapy system that controls protein synthesis to halt tumor growth. The current consensus EPS growth forecast for next year, with GURU.Markets data illustrated on this chart, shows a value of 63.30, reflecting the metric's status. Growth is driven by AI bioscreening models that automate drug discovery and strict adherence to batch release schedules in R&D laboratories.

EFTR: Prakiraan wutah bathi resik saben saham ing taun ngarep eEFFECTOR Therapeutics, Inc. 04.07.2022 - 04.08.2024

effector.com (EFTR) - rincian metrik lan laporan keuangan

- rega saham lan konsensus proyeksi valuasi:
Rega saham eEFFECTOR Therapeutics Inc.|EFTR - Rata-rata rega prakiraan
- data kapitalisasi bursa:
Nilai pasar eEFFECTOR Therapeutics|EFTR - Nilai Dipunlarasaken Utang lan Kas
- rincian nilai buku perusahaan:
Nilai Buku saben Saham eEFFECTOR Therapeutics|EFTR - Ekuitas Perusahaan|Rasio Kapitalisasi Pasar marang Nilai Buku effector.com|EFTR - Nilai Total Aset Perusahaan
- indikator total utang lan likuiditas perusahaan:
Total Utang marang Modal eFFECTOR Therapeutics|EFTR - Kewajiban jangka dawa marang ekuitas|Utang jangka cendhak marang modal eEFFECTOR Therapeutics|EFTR - Utang kumulatif perusahaan|Utang-utang marang kapitalisasi buku eEFFECTOR Therapeutics|EFTR - Kewajiban jangka dawa perusahaan|Kewajiban jangka cendhak perusahaan eEFFECTOR Therapeutics|Likuiditas cepet effector.com
- informasi bathi lan kelipatan valuasi:
EFTR - Penghasilan resik perusahaan|Bathi sing dikarepake eFFECTOR Therapeutics|EFTR - Nilai perusahaan marang bathi resik|Prakiraan rega marang bathi eFFECTOR Therapeutics|EFTR - Koefisien bali modal nimbang wutah|Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan eEFFECTOR Therapeutics|EFTR - Bathi perusahaan sadurunge pajak, bunga, lan amortisasi|Bathi resik saben saham (EPS TTM) eEFFECTOR Therapeutics|EFTR - Bathi saben saham sajroning taun lumaku|Wutah bathi EPS kuartalan effector.com|EFTR - Kacepetan wutah bathi saben saham ing taun lumaku|Prakiraan wutah bathi resik saben saham kanggo taun ngarep eFFECTOR Therapeutics
Analisis fundamental perusahaan:eEFFECTOR Therapeutics Inc., EFTR
Produk dadi effector.com

Delegating clinical trials to CRO networks minimizes operational expenses for eFFECTOR Therapeutics (EFTR), directly impacting the business's future margins. This indicator aggregates daily adjustments to expert earnings forecasts, measuring the velocity of shifting market expectations; by analyzing the trajectory of forward-looking EPS estimates, an investor can determine the asset's recovery phase and avoid overpaying for an overheated stock price.

Analisis perusahaan pesaing

AVBP (ArriVent BioPharma, Inc) - Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi resik saben saham ing taun ngarep Lantern LTRN|Prakiraan wutah bathi resik saben saham kanggo taun ngarep bioAffinity Technologies (BIAF)